The Metroticket 2.0 is an example of integrated model based on tumor size, tumor number, and AFP level to determine the survival outcomes from HCC-related factors after liver transplantation, useful to refine selection criteria for LT for HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.